Technology News and Research

RSS

CalRHIO's statewide HIE system implemented in Orange County

The first site in CalRHIO's statewide health information exchange (HIE) system is live in Orange County at Coastal Communities Hospital. As a result of collaboration between CalRHIO and the local HIE effort, the Orange County Partnership Regional Health Information Organization (OCPRHIO), 23 hospital emergency departments over the next five months will have secure electronic access to critical medical information.

15 Oct 2009

AbbeyMoor Medical's The Spanner temporary prostatic stent insertion procedure receives Category I CPT code

AbbeyMoor Medical Inc. announced today they have been granted a Category I CPT code by the American Medical Association (AMA) for The Spanner(TM) temporary prostatic stent insertion procedure. This important action, effective in January 2010, upgrades The Spanner from a Category III emerging technology procedure code to a Category I procedure code for established procedures.

15 Oct 2009

Hoag Memorial Hospital implements PCTS' Amelior EDTracker software

Patient Care Technology Systems (PCTS), a subsidiary of Consulier Engineering, Inc., today announced that Hoag Memorial Hospital Presbyterian has implemented the company's Amelior EDTracker® solution to automatically track patients in its 66,000-census emergency department.

15 Oct 2009

Critical Pharmaceuticals to develop hGH nasal spray

Critical Pharmaceuticals, the speciality pharmaceuticals company, today announced that it had secured a £1.5m translation award from the Wellcome Trust to develop a nasal spray of Human Growth Hormone (hGH) using its proprietary CriticalSorb technology as an alternative to injection.

15 Oct 2009

DNA authentication technology to distinguish between in-vivo and in-vitro DNA

Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.

15 Oct 2009

Healthways announces acquisition of behavioral economics company, HealthHonors

Healthways, Inc. today announced the acquisition of HealthHonors, a market-leading behavioral economics company that specializes in behavior change science and optimized use of incentives, in a cash for stock transaction.

15 Oct 2009

Dramatic effects on Norway's health service

If we continue to use our hospitals in the same way as we do now, the health service in 2030 will need to employ every second young person in the country and increase hospital bed capacity by 5000.

15 Oct 2009

Positive data from Cardium Therapeutics' Matrix Phase 2b Excellarate trial

Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.

15 Oct 2009

Affymetrix unveils Axiom Genotyping Solution

Affymetrix, Inc. (Nasdaq:AFFX) today announced the launch of the Axiom Genotyping Solution, its next-generation array technology designed to match the significant rise in genetic content generated by government and privately funded sequencing projects.

From Beckman Coulter Life Sciences - Automation and Genomics 15 Oct 2009

Nano Gen Teknolojileri to distribute Fluidigm's BioMark and EP1 genetic analysis systems in Turkey

Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and EP1™ Systems for genetic analysis in Turkey. The BioMark System provides significant advantages for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection and absolute quantification.

15 Oct 2009

FDA approves ZyStor Therapeutics' ZC-701 for Phase I human safety trial

ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.

14 Oct 2009

Richmont Sciences to market PURE’s antimicrobial SDC disinfectants

PURE Bioscience announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, LLC, which will begin actively selling PURE’s revolutionary new antibacterial, antiviral and antifungal hard surface disinfectant and its active ingredient.

14 Oct 2009

Riga Eastern Clinical University Hospital commences treatment with the Novalis Tx radiosurgery platform

Doctors in Latvia have begun treatments using the region's first Novalis Tx(TM) radiosurgery platform from Varian Medical Systems and BrainLAB. Two prostate cancer patients have been treated using Varian's RapidArc® radiotherapy technology at the Riga Eastern Clinical University Hospital.

14 Oct 2009

Cochlear and NXP Semiconductors sign design and manufacturing agreement

Cochlear Limited, Australian based world leader in Implantable Hearing Solutions, and NXP Semiconductors announced today that they have signed an agreement for the design and manufacturing of IC devices for Cochlear’s future generation Implantable Hearing devices.

14 Oct 2009

Hyperlocal social media-marketing platform from TotalPaas

TotalPaas, Inc., a new Web-based technology innovator, today announces the launch of the company offering a hyperlocal social media-marketing platform for community leaders building personalized online communities.

14 Oct 2009

MAQUET Cardiovascular officially opens its new headquarters in Wayne

MAQUET Cardiovascular LLC, a leading, global provider of cardiovascular technologies, today celebrated and formally opened its new United States headquarters in Wayne, New Jersey. The dedication ceremony was attended by local and state dignitaries, the MAQUET leadership team, and local employees from the company's cardiovascular, critical care and surgical workplace divisions.

14 Oct 2009

Delegation from All-CABPA visits Sundia

A delegation from the Alliance of Chinese-American Biotechnology and Pharmaceutical Associations (All-CABPA) visited Sundia in Shanghai's famous Zhangjiang Hi-Tech Park on October 12.

14 Oct 2009

New non-invasive technology to measure glucose levels in the human eye

New non-invasive technology designed to painlessly measure glucose levels in the human eye shows promise of one day replacing the finger-stick blood test, according to results of a pre-clinical study funded by Freedom Meditech, Inc.

14 Oct 2009

GeckoSystems to discuss the CareBot's low cost differential drive locomotion system

GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) (http://www.geckosystems.com/) announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009, attendees will be able to observe and discuss the CareBot's™ low cost differential drive locomotion system.

14 Oct 2009

DIATHERIX Laboratories granted EUA for H1N1-09 Influenza Test

DIATHERIX Laboratories, Inc. is pleased to announce it has been granted emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its DIATHERIX H1N1-09 Influenza Test.

14 Oct 2009